Response to chloroquine of Plasmodium vivax among South Korean soldiers.
The response to standard chloroquine treatment was evaluated, by microscopical examination of blood-smears, among 81 soldiers diagnosed with Plasmodium vivax malaria in South Korea in 1996. The smears were prepared pre-treatment and 3, 14 and 28 days after starting chemotherapy. Parasitaemias were determined after staining the smears with Giemsa's stain. Blood samples from the patients who were not smear-negative by day 3 were carefully checked for parasites, by staining smears with Acridine Orange and by a PCR-based assay. Only two of the patients appeared to be parasitaemic on day 14 and were therefore considered treatment failures. Although both were apparently cured after additional therapy with the same regimen, one had a recurrence 8 months later. Most cases of recent, resurgent malaria in South Korea therefore appear to sensitive to chloroquine.
Lim
C S
CS
Department of Clinical Pathology, Korea University Ansan Hospital, Gojan Dong, Ansan City, South Korea. malarim@hitel.net
Kim
Y K
YK
Lee
K N
KN
Kim
M J
MJ
Kim
K H
KH
Kim
D S
DS
Strickman
D
D
D000328:Adult; D000818:Animals; D000962:Antimalarials / Q000627:therapeutic use*; D002738:Chloroquine / Q000627:therapeutic use*; D006801:Humans; D007723:Korea; D016780:Malaria, Vivax / Q000188:drug therapy*; D008297:Male; D018512:Parasitemia / Q000188:drug therapy; D010966:Plasmodium vivax; D016133:Polymerase Chain Reaction / Q000379:methods
D000962:Antimalarials; D002738:Chloroquine